Esperion Therapeutics Inc (ESPR)
2.015
-0.02
(-0.74%)
USD |
NASDAQ |
Nov 04, 12:53
Esperion Therapeutics 1 Year Total Returns (Daily): 136.3% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 136.3% |
October 31, 2024 | 146.1% |
October 30, 2024 | 157.8% |
October 29, 2024 | 168.5% |
October 28, 2024 | 175.0% |
October 25, 2024 | 175.4% |
October 24, 2024 | 152.9% |
October 23, 2024 | 157.7% |
October 22, 2024 | 159.4% |
October 21, 2024 | 150.9% |
October 18, 2024 | 128.7% |
October 17, 2024 | 124.0% |
October 16, 2024 | 153.6% |
October 15, 2024 | 156.6% |
October 14, 2024 | 151.8% |
October 11, 2024 | 143.2% |
October 10, 2024 | 105.7% |
October 09, 2024 | 121.8% |
October 08, 2024 | 109.1% |
October 07, 2024 | 106.1% |
October 04, 2024 | 138.2% |
October 03, 2024 | 102.6% |
October 02, 2024 | 87.63% |
October 01, 2024 | 64.29% |
September 30, 2024 | 68.37% |
Date | Value |
---|---|
September 27, 2024 | 70.40% |
September 26, 2024 | 56.19% |
September 25, 2024 | 62.22% |
September 24, 2024 | 66.63% |
September 23, 2024 | 64.61% |
September 20, 2024 | 46.09% |
September 19, 2024 | 41.13% |
September 18, 2024 | 34.88% |
September 17, 2024 | 25.35% |
September 16, 2024 | 23.94% |
September 13, 2024 | 48.06% |
September 12, 2024 | 30.60% |
September 11, 2024 | 30.83% |
September 10, 2024 | 24.46% |
September 09, 2024 | 22.30% |
September 06, 2024 | 14.58% |
September 05, 2024 | 17.01% |
September 04, 2024 | 16.67% |
September 03, 2024 | 17.31% |
August 30, 2024 | 14.38% |
August 29, 2024 | 7.36% |
August 28, 2024 | 7.59% |
August 27, 2024 | 23.91% |
August 26, 2024 | 27.54% |
August 23, 2024 | 27.34% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.98%
Minimum
Oct 26 2023
175.4%
Maximum
Oct 25 2024
-27.54%
Average
-43.67%
Median
1 Year Total Returns (Daily) Benchmarks
Perspective Therapeutics Inc | 359.7% |
Nektar Therapeutics | 153.6% |
Alaunos Therapeutics Inc | -83.21% |
Oragenics Inc | -92.31% |
Cocrystal Pharma Inc | 2.98% |